受强制性开放获取政策约束的文章 - Xueqing Nie了解详情
无法在其他位置公开访问的文章：1 篇
Development of selective FGFR1 degraders using a rapid synthesis of proteolysis targeting Chimera (Rapid-TAC) platform
L Guo, J Liu, X Nie, T Wang, Z Ma, D Yin, W Tang
Bioorganic & Medicinal Chemistry Letters 75, 128982, 2022
强制性开放获取政策： US National Institutes of Health
可在其他位置公开访问的文章：6 篇
Development of selective histone deacetylase 6 (HDAC6) degraders recruiting von Hippel–Lindau (VHL) E3 ubiquitin ligase
K Yang, H Wu, Z Zhang, ED Leisten, X Nie, B Liu, Z Wen, J Zhang, ...
ACS Medicinal Chemistry Letters 11 (4), 575-581, 2020
强制性开放获取政策： US National Institutes of Health
A cell-based target engagement assay for the identification of cereblon E3 ubiquitin ligase ligands and their application in HDAC6 degraders
K Yang, Y Zhao, X Nie, H Wu, B Wang, CM Almodovar-Rivera, H Xie, ...
Cell chemical biology 27 (7), 866-876. e8, 2020
强制性开放获取政策： US National Institutes of Health
In silico modeling and scoring of PROTAC-mediated ternary complex poses
J Liao, X Nie, IC Unarta, SS Ericksen, W Tang
Journal of Medicinal Chemistry 65 (8), 6116-6132, 2022
强制性开放获取政策： US National Science Foundation, US Department of Energy, US National …
A platform for the rapid synthesis of proteolysis targeting chimeras (Rapid-TAC) under miniaturized conditions
L Guo, Y Zhou, X Nie, Z Zhang, Z Zhang, C Li, T Wang, W Tang
European journal of medicinal chemistry 236, 114317, 2022
强制性开放获取政策： US National Institutes of Health
Evaluation of the binding affinity of E3 ubiquitin ligase ligands by cellular target engagement and in-cell ELISA assay
K Yang, Y Zhou, BL Roberts, X Nie, W Tang
STAR protocols 2 (1), 100288, 2021
强制性开放获取政策： US National Institutes of Health
Development of Phenyl‐substituted Isoindolinone‐and Benzimidazole‐type Cereblon Ligands for Targeted Protein Degradation
X Nie, Y Zhao, H Tang, Z Zhang, J Liao, CM Almodovar‐Rivera, ...
ChemBioChem 25 (4), e202300685, 2024
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定